DE60104589D1 - Therapeutisches Mittel zur Behandlung von Dermatitis - Google Patents

Therapeutisches Mittel zur Behandlung von Dermatitis

Info

Publication number
DE60104589D1
DE60104589D1 DE60104589T DE60104589T DE60104589D1 DE 60104589 D1 DE60104589 D1 DE 60104589D1 DE 60104589 T DE60104589 T DE 60104589T DE 60104589 T DE60104589 T DE 60104589T DE 60104589 D1 DE60104589 D1 DE 60104589D1
Authority
DE
Germany
Prior art keywords
therapeutic agent
dermatitis
reaction
atopic dermatitis
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60104589T
Other languages
English (en)
Other versions
DE60104589T2 (de
Inventor
Haruo Yoshii
Akihiro Fujita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60104589D1 publication Critical patent/DE60104589D1/de
Publication of DE60104589T2 publication Critical patent/DE60104589T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60104589T 2000-04-13 2001-04-12 Therapeutisches Mittel zur Behandlung von Dermatitis Expired - Fee Related DE60104589T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000111809 2000-04-13
JP2000111809 2000-04-13

Publications (2)

Publication Number Publication Date
DE60104589D1 true DE60104589D1 (de) 2004-09-09
DE60104589T2 DE60104589T2 (de) 2005-07-28

Family

ID=18624080

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60104589T Expired - Fee Related DE60104589T2 (de) 2000-04-13 2001-04-12 Therapeutisches Mittel zur Behandlung von Dermatitis

Country Status (10)

Country Link
US (1) US6440978B2 (de)
EP (1) EP1145716B1 (de)
KR (1) KR20010098583A (de)
CN (1) CN1192776C (de)
AT (1) ATE272403T1 (de)
AU (1) AU775851B2 (de)
CA (1) CA2344182A1 (de)
DE (1) DE60104589T2 (de)
ES (1) ES2223676T3 (de)
TW (1) TWI243055B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
FR2832711B1 (fr) 2001-11-26 2004-01-30 Warner Lambert Co Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
TW200800997A (en) * 2006-03-22 2008-01-01 Astrazeneca Ab Chemical compounds
SA08280783B1 (ar) * 2007-01-11 2011-04-24 استرازينيكا ايه بي مشتقات بيريدوبيريميدين كمثبطات pde4
TWI483729B (zh) 2010-03-11 2015-05-11 Nippon Zoki Pharmaceutical Co 慢性前列腺炎、間質性膀胱炎及／或排尿障礙之改善或治療劑
AU2011316756B2 (en) 2010-10-14 2015-01-22 Nippon Zoki Pharmaceutical Co., Ltd A method for promoting the synthesis of collagen and proteoglycan in chondrocytes

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB989048A (en) 1962-08-02 1965-04-14 Mead Johnson & Co Pyrido[2,3-d]pyrimidines
US3235554A (en) 1963-11-12 1966-02-15 Searle & Co 7-amino-1-methyl-2, 4-dioxo-1, 2, 3, 4, 5, 6-hexahydropyrido[2, 3-d]-pyrimidine and related compounds
US3272816A (en) 1965-04-28 1966-09-13 Searle & Co 7-amino-2, 4-dioxo-1, 2, 3, 4-tetrahydropyrido[2, 3-d]pyrimidines
US3275634A (en) 1965-09-02 1966-09-27 Searle & Co 7-hydroxy-2, 4-dioxo-1, 2, 3, 4, 5, 6-hexahydropyrido[2, 3-d]pyrimidines
LU65139A1 (de) 1972-04-07 1973-10-22
GB1401549A (en) 1972-07-07 1975-07-16 Hisamitsu Pharmaceutical Co Pyrido-2,3-d-pyrimidine-2,4-1h,3h- diones and methods of preparing them
JPS60226882A (ja) 1984-04-24 1985-11-12 Nippon Zoki Pharmaceut Co Ltd 新規ピリミドピリミジン誘導体
US4808587A (en) 1986-04-16 1989-02-28 Nippon Zoki Pharmaceutical Co., Ltd. 5-substituted pyrido[2,3-d]pyrimidine-2,4-diones
EP0260817B1 (de) 1986-08-21 1991-05-15 Pfizer Inc. Chinazolindione und Pyridopyrimidindione
DE4035479A1 (de) 1990-11-08 1992-05-14 Basf Ag Substituierte pyrido (2,3-d)pyrimidin-2,4(1h,3h)-dione
US5264437A (en) 1992-03-20 1993-11-23 Syntex (U.S.A.) Inc. Optionally substituted pyrido[2,3-d]pyridine-2,4(1H,3H)-diones and pyrido[2,]pyrimidine-2(1H,3H)-ones
JP3113440B2 (ja) 1992-03-25 2000-11-27 日本臓器製薬株式会社 ピリジニウム誘導体
CA2166721C (en) * 1993-07-06 1999-07-27 Allen Jacob Duplantier Bicyclic tetrahydro pyrazolopyridines
US5776942A (en) 1994-06-17 1998-07-07 Nippon Zoki Pharmaceutical Co., Ltd. Bronchodilating pyrido 2,3-d!pyrimidine derivatives
JP3242792B2 (ja) 1994-08-05 2001-12-25 日本臓器製薬株式会社 ナフチリジニウム誘導体
JP2000119272A (ja) 1998-10-15 2000-04-25 Nippon Zoki Pharmaceut Co Ltd 新規７−アミノピリド〔２，３−ｄ〕ピリミジン誘導体

Also Published As

Publication number Publication date
DE60104589T2 (de) 2005-07-28
AU775851B2 (en) 2004-08-19
KR20010098583A (ko) 2001-11-08
ATE272403T1 (de) 2004-08-15
CN1321465A (zh) 2001-11-14
ES2223676T3 (es) 2005-03-01
EP1145716B1 (de) 2004-08-04
TWI243055B (en) 2005-11-11
EP1145716A3 (de) 2002-06-12
CN1192776C (zh) 2005-03-16
US20010056097A1 (en) 2001-12-27
CA2344182A1 (en) 2001-10-13
US6440978B2 (en) 2002-08-27
AU3511601A (en) 2001-10-18
EP1145716A2 (de) 2001-10-17

Similar Documents

Publication Publication Date Title
TW200614983A (en) 5-substituted-2-phenylamino benzamides as MEK inhibitors
GB0318447D0 (en) Therapeutic agents
GB0225475D0 (en) Therapeutic agents
ATE381537T1 (de) Formanilid-derivative als beta2-adrenorezeptor- agonisten
BR0312729A (pt) Novos derivados de indol-3-enxofre
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
HUP0401192A2 (hu) Fényérzékenyítő szer alkalmazása sebek kezelésére adható gyógyászati készítmény előállítására
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
BRPI0418074B8 (pt) derivado de amida, composição farmacêutica, inibidor da tirosina cinase bcr-abl e agentes terapêuticos
BR0314754A (pt) Agente terapêutico ou profilático para a frequência urinária ou a incontinência urinária ou um seu sal de adição de ácido farmaceuticamente aceitável, método para terapia ou profilaxia para frequência urinária, urgência urinária ou incontinência urinária, uso de um derivado de morfina tendo um grupo heterocìclico contendo nitrogênio ou de um seu sal de adição de ácido farmaceuticamente aceitável, derivado de morfina ou um seu sal de adição de ácido farmaceuticamente aceitável, produto farmacêutico, e, composição farmacêutica
NO20005912L (no) Sulfonylsyre- eller sulfonylamino-N-(heteroaralkyl)- azaheterocyklylamidforbindelser
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
DE60031686D1 (de) Pyrazinone, diese verbindungen enthaltende zusammenstellungen
BR0311363A (pt) Formulação farmacêutica de liberação imediata, uso da mesma, e, método para tratar um distúrbio cardiovascular em um paciente
ATE272403T1 (de) Therapeutisches mittel zur behandlung von dermatitis
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
NO971743L (no) Farmasöytisk sammensetning for profylakse og behandling av type I allergiske sykdommer
MX2023000437A (es) Derivado de bencisoxazol.
AU2001266019A1 (en) 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
EP1291349A4 (de) Malto-oligosaccharide und deren verwendung
ATE369849T1 (de) Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen
GB0229022D0 (en) Organic Compounds
HUP0402072A2 (hu) 1,3-Oxazol- vagy -tiazolgyűrűt tartalmazó glicinszármazékok és ezeket a vegyületeket hatóanyagként tartalmazó szerek
EA200501591A1 (ru) Фармацевтическая комбинация для лечения мышечной спастичности и/или боли
SG146685A1 (en) Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee